Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

673 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Gut microbiome and multiple sclerosis.
Bhargava P, Mowry EM. Bhargava P, et al. Curr Neurol Neurosci Rep. 2014 Oct;14(10):492. doi: 10.1007/s11910-014-0492-2. Curr Neurol Neurosci Rep. 2014. PMID: 25204849 Review.
The expanding spectrum of aetiologies causing retinal microcystic macular change.
Bhargava P, Calabresi PA. Bhargava P, et al. Brain. 2013 Nov;136(Pt 11):3212-4. doi: 10.1093/brain/awt295. Epub 2013 Oct 16. Brain. 2013. PMID: 24131594 Free PMC article. No abstract available.
Right brain: humor completes the neurologic examination.
Bhargava P. Bhargava P. Neurology. 2014 Jan 21;82(3):e21-2. doi: 10.1212/WNL.0000000000000035. Neurology. 2014. PMID: 24446178 No abstract available.
Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics.
Vidaurre OG, Haines JD, Katz Sand I, Adula KP, Huynh JL, McGraw CA, Zhang F, Varghese M, Sotirchos E, Bhargava P, Bandaru VV, Pasinetti G, Zhang W, Inglese M, Calabresi PA, Wu G, Miller AE, Haughey NJ, Lublin FD, Casaccia P. Vidaurre OG, et al. Among authors: bhargava p. Brain. 2014 Aug;137(Pt 8):2271-86. doi: 10.1093/brain/awu139. Epub 2014 Jun 3. Brain. 2014. PMID: 24893707 Free PMC article.
The vitamin D to ameliorate multiple sclerosis (VIDAMS) trial: study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis.
Bhargava P, Cassard S, Steele SU, Azevedo C, Pelletier D, Sugar EA, Waubant E, Mowry EM. Bhargava P, et al. Contemp Clin Trials. 2014 Nov;39(2):288-93. doi: 10.1016/j.cct.2014.10.004. Epub 2014 Oct 12. Contemp Clin Trials. 2014. PMID: 25311447 Clinical Trial.
1,25-Dihydroxyvitamin D3 impairs the differentiation of effector memory T cells in vitro in multiple sclerosis patients and healthy controls.
Bhargava P, Gocke A, Calabresi PA. Bhargava P, et al. J Neuroimmunol. 2015 Feb 15;279:20-4. doi: 10.1016/j.jneuroim.2014.12.018. Epub 2015 Jan 3. J Neuroimmunol. 2015. PMID: 25669995
Novel therapies for memory cells in autoimmune diseases.
Bhargava P, Calabresi PA. Bhargava P, et al. Clin Exp Immunol. 2015 Jun;180(3):353-60. doi: 10.1111/cei.12602. Epub 2015 Apr 23. Clin Exp Immunol. 2015. PMID: 25682849 Free PMC article. Review.
Applying an Open-Source Segmentation Algorithm to Different OCT Devices in Multiple Sclerosis Patients and Healthy Controls: Implications for Clinical Trials.
Bhargava P, Lang A, Al-Louzi O, Carass A, Prince J, Calabresi PA, Saidha S. Bhargava P, et al. Mult Scler Int. 2015;2015:136295. doi: 10.1155/2015/136295. Epub 2015 May 18. Mult Scler Int. 2015. PMID: 26090228 Free PMC article.
Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year study.
Saidha S, Al-Louzi O, Ratchford JN, Bhargava P, Oh J, Newsome SD, Prince JL, Pham D, Roy S, van Zijl P, Balcer LJ, Frohman EM, Reich DS, Crainiceanu C, Calabresi PA. Saidha S, et al. Among authors: bhargava p. Ann Neurol. 2015 Nov;78(5):801-13. doi: 10.1002/ana.24487. Epub 2015 Oct 1. Ann Neurol. 2015. PMID: 26190464 Free PMC article.
RESULTS: Rates of ganglion cell + inner plexiform layer (GCIP) and whole-brain (r = 0.45; p < 0.001), gray matter (GM; r = 0.37; p < 0.001), white matter (WM; r = 0.28; p = 0.007), and thalamic (r = 0.38; p < 0.001) atrophy were associated. .. …
RESULTS: Rates of ganglion cell + inner plexiform layer (GCIP) and whole-brain (r = 0.45; p < 0.001), gray matter (GM; r = 0.37; …
Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls.
Bhargava P, Steele SU, Waubant E, Revirajan NR, Marcus J, Dembele M, Cassard SD, Hollis BW, Crainiceanu C, Mowry EM. Bhargava P, et al. Mult Scler. 2016 May;22(6):753-60. doi: 10.1177/1352458515600248. Epub 2015 Aug 18. Mult Scler. 2016. PMID: 26286698 Free PMC article.
There was no significant difference in baseline 25(OH)D level or demographics except for higher body mass index (BMI) in the MS group (25.3 vs. 23.6 kg/m(2), p=0.035). ...In a multivariate model accounting for BMI, medication adherence, and oral contraceptive use, MS patie …
There was no significant difference in baseline 25(OH)D level or demographics except for higher body mass index (BMI) in the MS group (25.3 …
673 results
Jump to page
Feedback